Literature DB >> 23546445

Heart failure: Aldosterone antagonism for HFpEF.

Barry A Borlaug.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23546445     DOI： 10.1038/nrcardio.2013.51

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN： 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  10 in total

1.  Trends in prevalence and outcome of heart failure with preserved ejection fraction.

Authors:  Theophilus E Owan; David O Hodge; Regina M Herges; Steven J Jacobsen; Veronique L Roger; Margaret M Redfield
Journal:  N Engl J Med       Date:  2006-07-20       Impact factor: 91.245

2.  Global cardiovascular reserve dysfunction in heart failure with preserved ejection fraction.

Authors:  Barry A Borlaug; Thomas P Olson; Carolyn S P Lam; Kelly S Flood; Amir Lerman; Bruce D Johnson; Margaret M Redfield
Journal:  J Am Coll Cardiol       Date:  2010-09-07       Impact factor: 24.094

3.  Rationale and design of the treatment of preserved cardiac function heart failure with an aldosterone antagonist trial: a randomized, controlled study of spironolactone in patients with symptomatic heart failure and preserved ejection fraction.

Authors:  Akshay S Desai; Eldrin F Lewis; Rebecca Li; Scott D Solomon; Susan F Assmann; Robin Boineau; Nadine Clausell; Rafael Diaz; Jerome L Fleg; Ivan Gordeev; Sonja McKinlay; Eileen O'Meara; Tamaz Shaburishvili; Bertram Pitt; Marc A Pfeffer
Journal:  Am Heart J       Date:  2011-11-08       Impact factor: 4.749

Review 4.  Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment.

Authors:  Barry A Borlaug; Walter J Paulus
Journal:  Eur Heart J       Date:  2010-12-07       Impact factor: 29.983

5.  Effects of eplerenone, enalapril, and eplerenone/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy study.

Authors:  Bertram Pitt; Nathaniel Reichek; Roland Willenbrock; Faiez Zannad; Robert A Phillips; Barbara Roniker; Jay Kleiman; Scott Krause; Daniel Burns; Gordon H Williams
Journal:  Circulation       Date:  2003-09-29       Impact factor: 29.690

6.  Cardiac output response to exercise in relation to metabolic demand in heart failure with preserved ejection fraction.

Authors:  Muaz M Abudiab; Margaret M Redfield; Vojtech Melenovsky; Thomas P Olson; David A Kass; Bruce D Johnson; Barry A Borlaug
Journal:  Eur J Heart Fail       Date:  2013-02-20       Impact factor: 15.534

7.  Effect of spironolactone on diastolic function and exercise capacity in patients with heart failure with preserved ejection fraction: the Aldo-DHF randomized controlled trial.

Authors:  Frank Edelmann; Rolf Wachter; Albrecht G Schmidt; Elisabeth Kraigher-Krainer; Caterina Colantonio; Wolfram Kamke; André Duvinage; Raoul Stahrenberg; Kathleen Durstewitz; Markus Löffler; Hans-Dirk Düngen; Carsten Tschöpe; Christoph Herrmann-Lingen; Martin Halle; Gerd Hasenfuss; Götz Gelbrich; Burkert Pieske
Journal:  JAMA       Date:  2013-02-27       Impact factor: 56.272

8.  Effect of aldosterone antagonism on myocardial dysfunction in hypertensive patients with diastolic heart failure.

Authors:  Philip M Mottram; Brian Haluska; Rodel Leano; Diane Cowley; Michael Stowasser; Thomas H Marwick
Journal:  Circulation       Date:  2004-07-26       Impact factor: 29.690

9.  Effect of angiotensin receptor blockade and antihypertensive drugs on diastolic function in patients with hypertension and diastolic dysfunction: a randomised trial.

Authors:  Scott D Solomon; Rajesh Janardhanan; Anil Verma; Mikhail Bourgoun; William L Daley; Das Purkayastha; Yves Lacourcière; Stephen E Hippler; Harold Fields; Tasneem Z Naqvi; Sharon L Mulvagh; J Malcolm O Arnold; James D Thomas; Michael R Zile; Gerard P Aurigemma
Journal:  Lancet       Date:  2007-06-23       Impact factor: 79.321

10.  Determinants of ventilatory efficiency in heart failure: the role of right ventricular performance and pulmonary vascular tone.

Authors:  Gregory D Lewis; Ravi V Shah; Paul P Pappagianopolas; David M Systrom; Marc J Semigran
Journal:  Circ Heart Fail       Date:  2008-11       Impact factor: 8.790
  10 in total
  2 in total

1.  Beta-blockers and inhibitors of the renin-angiotensin aldosterone system for chronic heart failure with preserved ejection fraction.

Authors:  Nicole Martin; Karthick Manoharan; Ceri Davies; R Thomas Lumbers
Journal:  Cochrane Database Syst Rev       Date:  2021-05-22

Review 2.  Beta-blockers and inhibitors of the renin-angiotensin aldosterone system for chronic heart failure with preserved ejection fraction.

Authors:  Nicole Martin; Karthick Manoharan; James Thomas; Ceri Davies; R Thomas Lumbers
Journal:  Cochrane Database Syst Rev       Date:  2018-06-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.